ArticleBMC endocrine disorders2026
Association between non-traditional lipid-inflammatory parameters and incident diabetes: a national prospective cohort study.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundNon-traditional lipid indices are diabetes risk factors, but their combined effects with inflammatory markers remain unclear. The present study systematically investigated and compared the associations between eight non-traditional lipid-inflammatory parameters and new-onset diabetes.
methodsData were obtained from the 2011-2020 China Health and Retirement Longitudinal Study. The lipid-inflammatory parameters were created by integrating non-traditional lipid indices and high-sensitivity C-reactive protein (hsCRP). Cox regression and restricted cubic spline models examined the associations of baseline and cumulative lipid-inflammatory parameters with diabetes risk. Time-dependent receiver operating characteristic analyses evaluated the predictive performance of these parameters. Mediation analyses explored the reciprocal links between non-traditional lipid indices, hsCRP, and diabetes risk.
resultsThe study enrolled 7,356 participants, with 1,173 (15.95%) developing diabetes over a median follow-up period of 9 years. In the multivariable-adjusted model, individuals with higher baseline and cumulative non-traditional lipid-inflammatory parameter levels had an elevated risk of developing diabetes, especially for lipoprotein combined index (LCI)-hsCRP (hazard ratio [HR] = 2.03, 95% confidence interval [CI]: 1.70-2.41). All lipid-inflammatory parameters were nonlinearly associated with diabetes risk. The area under the curve (AUC) values for the eight lipid-inflammatory parameters ranged from 0.595 to 0.619, with LCI-hsCRP exhibiting the highest predictive value (AUC = 0.619, 95% CI: 0.597-0.640). The results were consistent across sensitivity and subgroup analyses. Mediation analyses showed significant bidirectional mediation between non-traditional lipid indices and hsCRP for diabetes.
conclusionsElevated baseline and cumulative non-traditional lipid-inflammatory parameter levels are linked to a higher risk of incident diabetes, with LCI-hsCRP showing the highest predictive value. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.